Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
NCT06078098
Summary
Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver transplantation. No AIH-specific registry does exist in Italy, so that the actual epidemiology of the disease in the country is unknown. This is an observational, retrospective and prospective, multicenter study evaluating incidence, prevalence and disease course of AIH in subjects \> 1 years old in Italy.
Eligibility
Inclusion Criteria: * All AIH patients living in Italy and aged at least 1 year can be included in the database. * Willing and able to give informed consent prior to any study specific procedure being * Diagnosis of AIH according to the most recent published guidelines (EASL) Exclusion Criteria: * Subject unwilling to participate at the study
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06078098